Zydus Wellness Ltd
NSE:ZYDUSWELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (35.7), the stock would be worth ₹308.56 (37% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 56.9 | ₹491.7 |
0%
|
| 3-Year Average | 35.7 | ₹308.56 |
-37%
|
| 5-Year Average | 35.6 | ₹307.81 |
-37%
|
| Industry Average | 24.2 | ₹209.48 |
-57%
|
| Country Average | 23.3 | ₹201.21 |
-59%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹152.2B
|
/ |
Jan 2026
₹3.2B
|
= |
|
|
₹152.2B
|
/ |
Mar 2026
₹3.8B
|
= |
|
|
₹152.2B
|
/ |
Mar 2027
₹5.4B
|
= |
|
|
₹152.2B
|
/ |
Mar 2028
₹7.1B
|
= |
|
|
₹152.2B
|
/ |
Mar 2029
₹8.4B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Zydus Wellness Ltd
NSE:ZYDUSWELL
|
156.2B INR | 56.9 | 75.5 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 318 284.3 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
208.8B CHF | 17.7 | 22.9 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
73.6B USD | 25 | 30 | |
| FR |
|
Danone SA
PAR:BN
|
42.6B EUR | 13.2 | 23.5 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
48.6B ZAR | 11.5 | 12.7 | |
| US |
|
Hershey Co
NYSE:HSY
|
37.8B USD | 27.8 | 42.8 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
235.7B CNY | 21.7 | 23.9 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
233.2B CNY | 24.9 | 33.1 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.1B ZAR | 8.7 | 12.8 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.5B CHF | 24.8 | 32 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Zydus Wellness Ltd
Glance View
Zydus Wellness Ltd. weaves its narrative by fusing health-conscious innovation with strategic market positioning. Originating as an offshoot of the pharmaceutical giant Cadila Healthcare, Zydus Wellness was established to harness the rising tide of the wellness revolution in India. At the heart of its portfolio are brands like Sugar Free, Everyuth, and Nutralite, each carefully cultivated to address specific consumer demands for healthier lifestyle choices. Sugar Free, a leader in the artificial sweetener space, capitalizes on the growing diabetic and diet-conscious population, while Everyuth's exfoliating and skincare ranges tap into beauty and personal care. Meanwhile, Nutralite tackles the shift towards healthier dietary options with its line of cholesterol-free butter alternatives. This diverse portfolio highlights Zydus Wellness’s grasp of consumer insights and its ability to align product innovation with societal trends. The company’s financial tapestry is woven from the threads of brand loyalty and expansive distribution channels. Its approach deftly combines strong marketing strategies with a robust distribution framework, ensuring that its products readily reach varied consumer bases across urban and rural landscapes. Zydus Wellness leverages its relationship with Zydus Cadila to benefit from shared resources and synergies in research and development, enhancing its capacity for product refinement and innovation. This symbiotic relationship strengthens its market presence and supports its financial growth. By effectively managing its brand portfolio and continuously expanding its market reach, Zydus Wellness not only sustains its revenue streams but also solidifies its standing in the competitive wellness segment. Through strategic foresight and customer-centric product evolution, Zydus Wellness navigates the dynamic landscape, thriving amidst the increasing consumer gravitation towards healthier alternatives.